HCW Biologics Inc.

NASDAQ (USD): HCW Biologics Inc. (HCWB)

Last Price

1.68

Today's Change

+1.37 (456.29%)

Day's Change

0.85 - 1.83

Trading Volume

378,485,400

Overview

Market Cap

63 Million

Shares Outstanding

37 Million

Avg Volume

49,329

Avg Price (50 Days)

0.49

Avg Price (200 Days)

0.93

PE Ratio

-1.60

EPS

-1.05

Earnings Announcement

12-Nov-2024

Previous Close

0.30

Open

0.91

Day's Range

0.85 - 1.83

Year Range

0.276 - 1.93

Trading Volume

378,561,344

Price Change Highlight

1 Day Change

456.48%

5 Day Change

448.30%

1 Month Change

223.01%

3 Month Change

236.00%

6 Month Change

52.73%

Ytd Change

40.00%

1 Year Change

55.56%

3 Year Change

-41.26%

5 Year Change

-73.33%

10 Year Change

-73.33%

Max Change

-73.33%

News and Blogs
Latest Hottest Following

No result.

Company Profile

Sector: Healthcare - Healthcare

Industry: Biotechnology

Description:

HCW Biologics Inc., a preclinical stage biopharmaceutical company, focuses on discovering and developing novel immunotherapies for chronic, low-grade inflammation, and age-related diseases. The company's lead products include HCW9218, which is an injectable immunotherapeutic for patients with pancreatic, ovarian, breast, prostate, and colorectal cancers, as well as pulmonary fibrosis; and HCW9302 for auto-immune diseases, such as alopecia areata and metabolic diseases. It also develops HCW9201, a cell-based therapy that is in Phase II clinical trials for the treatment of patients with relapsed/refractory acute myeloid leukemia; and HCW9206 for the treatment of acute myeloid leukemia. The company was incorporated in 2018 and is headquartered in Miramar, Florida.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment